Tradestie Institutional Equity Comparison Engine

AHCO vs NEOG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AHCO Overall Edge

AHCO Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AdaptHealth Corp. Common Stock (AHCO) driven by superior Valuation, Growth & Margin, Options & Structure while NEOG counters with relative strength in Momentum & Technical. Fundamentally, AHCO trades at 7.8x Forward P/E with 3.8% operating margin (+10.9% YoY revenue) versus NEOG at 35.2x Forward P/E and -0.8% operating margin (+6.5% YoY). In options structure, AHCO sits in SURGE (12th %ile IV; Dealer Gamma Walls on Pro) against NEOG sits in CONSOLIDATION (25th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AHCO
AHCO 7.8x vs NEOG 35.2x Fwd P/E
Growth & Margin Winner AHCO
Op Margin 3.8% vs -0.8% ยท YoY +10.9% vs +6.5%
Momentum & Technical Winner NEOG
1Y -20.9% vs +89.4% ยท 52W Pos 24% vs 58%
Options & Structure Winner AHCO
SURGE (12th %ile IV) vs CONSOLIDATION (25th %ile IV)
AHCO NASDAQ
AdaptHealth Corp. Common Stock
Services-Home Health Care Services
$7.20
-0.69% 1D
Market Cap $989.8M
1M Return +16.69%
1Y Return -20.88%
Forward P/E 7.8x
Unified AI Score
45.2 / 100 HOLD
Tech 29.0 Fund 46.0 Flow 54.0 Mom 60.0
NEOG NASDAQ
Neogen Corp
In Vitro & In Vivo Diagnostic Substances
$10.55
-2.76% 1D
Market Cap $2.4B
1M Return -11.94%
1Y Return +89.41%
Forward P/E 35.2x
Unified AI Score
45.2 / 100 HOLD
Tech 30.0 Fund 47.0 Flow 56.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AHCO -20.88% NEOG +89.41% Spread: +110.29 pp (NEOG Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period AHCO Revenue NEOG Revenue AHCO Op. Margin NEOG Op. Margin Margin Edge
FY2019 $530M $410M 5.5% 16.4% NEOG
FY2020 $1.06B $420M 6.8% 16.1% NEOG
FY2021 $2.45B $470M 9.2% 15.8% NEOG
FY2022 $2.97B $530M 6.4% 11.1% NEOG
FY2023 $3.20B $820M -18.7% 4.6% NEOG
FY2024 $3.26B $920M 8.1% 6.3% AHCO
FY2025 $3.24B $890M 2.8% -118.6% AHCO
FY2026 N/A $870M N/A -2.5% NEOG

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AHCO (4) vs NEOG (5)
Institutional Metric AHCO NEOG Criterion Row Winner
Market Capitalization Scale $989.8M $2.4B Larger Scale NEOG
Trailing P/E Ratio Valuation 7.8x 16.0x Lower Multiple AHCO
Forward P/E Ratio Valuation 7.8x 35.2x Lower Multiple AHCO
Revenue Growth (YoY) Growth +10.9% +6.5% Higher Growth AHCO
Operating Margin (TTM) Profitability 3.8% -0.8% Higher Margin AHCO
Net Profit Margin Profitability -11.8% -6.3% Higher Margin NEOG
Return on Equity (ROE) Capital Efficiency -28.4% -2.7% Higher ROE NEOG
52-Week Range Position Momentum 24% ($5โ€“$13) 58% ($5โ€“$14) Stronger Trend NEOG
Beta / 30D Volatility Risk Regime 0.17ฮฒ ยท 67% Vol 1.35ฮฒ ยท 41% Vol Lower Realized Risk NEOG
Unified Institutional Score Composite Signal 45.2 / 100 (HOLD) 45.2 / 100 (HOLD) Higher Composite Tie

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AHCO vs NEOG Buy Guide
AHCO SURGE
6d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 12th %ile
IV Regime Compressed (<25th %ile)
Live AHCO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NEOG CONSOLIDATION
43d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live NEOG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AHCO nor NEOG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.